David L. Bernstein

606 total citations
14 papers, 439 citations indexed

About

David L. Bernstein is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, David L. Bernstein has authored 14 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 3 papers in Cognitive Neuroscience. Recurrent topics in David L. Bernstein's work include Neurotransmitter Receptor Influence on Behavior (4 papers), MicroRNA in disease regulation (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). David L. Bernstein is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (4 papers), MicroRNA in disease regulation (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). David L. Bernstein collaborates with scholars based in United States, Switzerland and Italy. David L. Bernstein's co-authors include Slava Rom, Sachin Gajghate, Nancy L. Reichenbach, Yuri Persidsky, Rodrigo A. España, Viviana Zuluaga‐Ramirez, Boris Polyak, Zachary D. Brodnik, David S. Olton and Donald K. Ingram and has published in prestigious journals such as Journal of Neuroscience, Biological Psychiatry and The Journal of Infectious Diseases.

In The Last Decade

David L. Bernstein

14 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Bernstein United States 11 162 109 107 99 74 14 439
Mikhil Bamne United States 15 231 1.4× 87 0.8× 36 0.3× 19 0.2× 58 0.8× 22 579
Jinxia Zhou China 12 181 1.1× 122 1.1× 42 0.4× 37 0.4× 70 0.9× 32 576
Elena V. Filatova Russia 10 187 1.2× 73 0.7× 25 0.2× 84 0.8× 40 0.5× 37 360
Xiao Ke China 15 190 1.2× 79 0.7× 97 0.9× 33 0.3× 106 1.4× 35 499
Jordan J. Baechle United States 7 101 0.6× 101 0.9× 71 0.7× 46 0.5× 19 0.3× 20 496
Ana Cicvaric Austria 11 109 0.7× 84 0.8× 41 0.4× 28 0.3× 29 0.4× 22 355
Yudan Lv China 10 94 0.6× 76 0.7× 115 1.1× 10 0.1× 32 0.4× 56 383
Ricardo A. Leitão Portugal 10 94 0.6× 110 1.0× 71 0.7× 12 0.1× 143 1.9× 17 400
Verónica Vidal Spain 15 201 1.2× 72 0.7× 93 0.9× 19 0.2× 67 0.9× 36 658

Countries citing papers authored by David L. Bernstein

Since Specialization
Citations

This map shows the geographic impact of David L. Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Bernstein more than expected).

Fields of papers citing papers by David L. Bernstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Bernstein. The network helps show where David L. Bernstein may publish in the future.

Co-authorship network of co-authors of David L. Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Bernstein. A scholar is included among the top collaborators of David L. Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Bernstein. David L. Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bernstein, David L., et al.. (2023). Inactivation of ERK1/2 Signaling in Dopaminergic Neurons by Map Kinase Phosphatase MKP3 Regulates Dopamine Signaling and Motivation for Cocaine. Journal of Neuroscience. 44(5). e0727232023–e0727232023. 1 indexed citations
2.
Bernstein, David L., et al.. (2021). let-7 microRNAs: Their Role in Cerebral and Cardiovascular Diseases, Inflammation, Cancer, and Their Regulation. Biomedicines. 9(6). 606–606. 54 indexed citations
3.
Bernstein, David L. & Slava Rom. (2020). Let-7g* and miR-98 Reduce Stroke-Induced Production of Proinflammatory Cytokines in Mouse Brain. Frontiers in Cell and Developmental Biology. 8. 632–632. 24 indexed citations
4.
Bernstein, David L., Sachin Gajghate, Nancy L. Reichenbach, et al.. (2020). let-7g counteracts endothelial dysfunction and ameliorating neurological functions in mouse ischemia/reperfusion stroke model. Brain Behavior and Immunity. 87. 543–555. 22 indexed citations
5.
Bernstein, David L., et al.. (2019). Methylenedioxypyrovalerone (MDPV) impairs working memory and alters patterns of dopamine signaling in mesocorticolimbic substrates. Neuroscience Research. 155. 56–62. 11 indexed citations
6.
Atmar, Robert L., Frank Baehner, Jakob P. Cramer, et al.. (2019). Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination. The Journal of Infectious Diseases. 220(4). 603–614. 22 indexed citations
7.
Bernstein, David L., Viviana Zuluaga‐Ramirez, Sachin Gajghate, et al.. (2019). miR-98 reduces endothelial dysfunction by protecting blood–brain barrier (BBB) and improves neurological outcomes in mouse ischemia/reperfusion stroke model. Journal of Cerebral Blood Flow & Metabolism. 40(10). 1953–1965. 98 indexed citations
8.
Bernstein, David L., et al.. (2017). Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine. Addiction Biology. 23(5). 1032–1045. 35 indexed citations
9.
Abbott, Rosalyn D., et al.. (2015). Non-invasive Assessments of Adipose Tissue Metabolism In Vitro. Annals of Biomedical Engineering. 44(3). 725–732. 6 indexed citations
10.
Brodnik, Zachary D., et al.. (2015). Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep. Behavioural Brain Research. 291. 377–384. 38 indexed citations
11.
Hernández, Giovanni, Erik B. Oleson, Ronny N. Gentry, et al.. (2013). Endocannabinoids Promote Cocaine-Induced Impulsivity and Its Rapid Dopaminergic Correlates. Biological Psychiatry. 75(6). 487–498. 39 indexed citations
12.
Hernández, Giovanni, David L. Bernstein, Geoffrey Schoenbaum, & Joseph F. Cheer. (2011). Contrasting Effects of Lithium Chloride and CB1 Receptor Blockade on Enduring Changes in the Valuation of Reward. Frontiers in Behavioral Neuroscience. 5. 53–53. 4 indexed citations
13.
Bernstein, David L., David S. Olton, Donald K. Ingram, et al.. (1985). Radial maze performance in young and aged mice: Neurochemical correlates. Pharmacology Biochemistry and Behavior. 22(2). 301–307. 48 indexed citations
14.
Kaufman, Howard H., Terry K. Satterwhite, Adam Borit, et al.. (1983). Deep Vein Thrombosis and Pulmonary Embolism in Head Injured Patients. Angiology. 34(10). 627–638. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026